August 11, 2025

From Lows to Highs? Inside ADBE’s Make-Or-Break Moment

Adobe (ADBE) is nearing near its 52-week lows at $340, amid pressure from AI competition and negative sentiment.

Charlie Moon reveals how he would consider trading ADBE, what he believes could be the stock’s “make-or-break” moment, and he reviews a few other broader market trends.

Charlie covers:

  • ADBE’s defense of key support and potential for a $360 breakout or $320 collapse
  • His August 22 out-of-the-money strangle strategy for $360 calls/$320 puts
  • Technical resistance at $325-$326 and the risk of a LULU-like meltdown
  • AI-driven sentiment challenges from platforms like ChatGPT and Grok
  • Apple and Nvidia’s influence on market momentum, especially Nasdaq
  • Cloud sector struggles (Snowflake, Datadog) and crypto’s bullish surge

Want More From the Prosper Team?

Mike Shorr is hosting a FREE live training at 8 PM Eastern tonight to outline how his 3-step options system is designed to help traders potentially hit their profit targets in under 60 minutes.

>>>Click here to save your seat

about the author:

Prosper Trading Academy

Read Similar Articles

https://www.prospertrading.com/exxon-mobil-stock-scotts-bearish-trade-idea-went-up-50/Exxon Mobil Stock: Scott’s Bearish Trade Idea Went Up 50%
December 4, 2025

Exxon Mobil Stock: Scott’s Bearish Trade Idea Went Up 50%

Despite being up almost 18% since April, Exxon Mobil stock (XOM) has seen a lot of ups and downs in 2025. Although XOM has been in an overall uptrend since the spring, Scott Bauer says there’s been a “sell the rally” trend—not just in Exxon Mobil stock—but in the broader oil space. Scott featured Exxon […]

Read Article
https://www.prospertrading.com/straddle-vs-strangle-when-can-each-strategy-offer-unlimited-risk/Straddle vs Strangle: When Can Each Strategy Offer Unlimited Risk?
December 2, 2025

Straddle vs Strangle: When Can Each Strategy Offer Unlimited Risk?

The straddle vs strangle debate has challenged many options traders. What do they mean? How do they work? How much risk in each one? While both strategies have big differences, they also possess some notable similarities… …including trading scenarios where each one can offer unlimited risk. Scott Bauer broke down the straddle vs strangle topic […]

Read Article
https://www.prospertrading.com/eli-lilly-stock-whats-next-for-wall-street-standout/Eli Lilly Stock: What’s Next For “Wall Street Standout”?
November 28, 2025

Eli Lilly Stock: What’s Next For “Wall Street Standout”?

Powered by news of its popular diabetes and weight loss drugs, Eli Lilly stock (LLY) has been on a tear in 2025. The stock is up over 38% this year, whose price crossed $1,000 for the first time ever in November. The big run Eli Lilly stock is on has a lot of traders wondering: […]

Read Article

Read Similar Articles

https://www.prospertrading.com/exxon-mobil-stock-scotts-bearish-trade-idea-went-up-50/Exxon Mobil Stock: Scott’s Bearish Trade Idea Went Up 50%
December 4, 2025

Exxon Mobil Stock: Scott’s Bearish Trade Idea Went Up 50%

Despite being up almost 18% since April, Exxon Mobil stock (XOM) has seen a lot of ups and downs in 2025. Although XOM has been in an overall uptrend since the spring, Scott Bauer says there’s been a “sell the rally” trend—not just in Exxon Mobil stock—but in the broader oil space. Scott featured Exxon […]

Read Article
https://www.prospertrading.com/straddle-vs-strangle-when-can-each-strategy-offer-unlimited-risk/Straddle vs Strangle: When Can Each Strategy Offer Unlimited Risk?
December 2, 2025

Straddle vs Strangle: When Can Each Strategy Offer Unlimited Risk?

The straddle vs strangle debate has challenged many options traders. What do they mean? How do they work? How much risk in each one? While both strategies have big differences, they also possess some notable similarities… …including trading scenarios where each one can offer unlimited risk. Scott Bauer broke down the straddle vs strangle topic […]

Read Article
https://www.prospertrading.com/eli-lilly-stock-whats-next-for-wall-street-standout/Eli Lilly Stock: What’s Next For “Wall Street Standout”?
November 28, 2025

Eli Lilly Stock: What’s Next For “Wall Street Standout”?

Powered by news of its popular diabetes and weight loss drugs, Eli Lilly stock (LLY) has been on a tear in 2025. The stock is up over 38% this year, whose price crossed $1,000 for the first time ever in November. The big run Eli Lilly stock is on has a lot of traders wondering: […]

Read Article